Rhodium-catalyzed reaction produces tertiary alcohols and azetidinols, indicating a new method for drug discovery.
Herein, we report a rhodium-catalyzed chemo-divergent reaction of oxetan-3-one and azetidin-3-ones with arylboronic acids. Ligand and temperature control selectively provide access to either tertiary alcohols (3-aryl oxetanols/azetidinols) via direct carbonyl addition or α-oxy/α-amino ketones via β-carbon elimination-initiated ring opening. This methodology bypasses stoichiometric organometallic reagents and specialized precursors, offering broad functional group tolerance and efficient access to carboxylic acid bioisosteres, while establishing a versatile catalytic platform for diversifying aliphatic small-ring systems in drug discovery.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: